Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	135.38	142.71	148.64	57.24	175.69	45.01
Short-Term Investments	352.16	484.19	489.44	534.85	376.09	131.99
Cash & Short-Term Investments	487.55	626.91	638.08	592.09	551.77	177
Cash Growth	-32.43%	-1.75%	7.77%	7.31%	211.74%	25.21%
Accounts Receivable	1.1	1.47	0.87	0.99	2.77	1.82
Receivables	1.1	1.47	0.87	0.99	2.77	1.82
Prepaid Expenses	11.61	6.89	6.01	7.23	4.48	2.96
Total Current Assets	500.25	635.26	644.96	600.3	559.02	181.78
Property, Plant & Equipment	16.5	18.22	18.85	16.91	12.52	6.88
Long-Term Investments	137.3	127.5	292.79	128.68	-	-
Long-Term Deferred Tax Assets	11.05	9.67	0.8	0.51	0.47	0.52
Other Long-Term Assets	9.19	7.5	7.4	7.75	-	-
Total Assets	674.28	798.14	964.8	754.15	572.01	189.19
Accounts Payable	4.79	5.07	8.6	8.49	3.82	3.04
Accrued Expenses	24.53	22.75	17.03	13.38	9.78	7.76
Current Portion of Leases	1.46	1.37	1.3	0.49	0.61	0.27
Current Income Taxes Payable	1.83	5.69	0.35	-	-	-
Current Unearned Revenue	-	-	-	-	-	3.64
Other Current Liabilities	0.44	0.71	-	0.34	0.12	0.07
Total Current Liabilities	33.05	35.59	27.27	22.7	14.32	14.78
Long-Term Leases	7.26	7.65	9.6	9.95	7.65	3.05
Total Liabilities	40.3	43.24	36.88	32.65	21.97	17.83
Common Stock	1,469	1,457	1,436	1,065	790.9	405.48
Additional Paid-In Capital	213.89	199.15	156.76	142.11	117.5	45.36
Retained Earnings	-1,049	-899.47	-665.14	-482.75	-357.37	-278.49
Comprehensive Income & Other	0.11	-1.61	-0.08	-3	-0.99	-0.99
Shareholders' Equity	633.98	754.9	927.92	721.5	550.03	171.36
Total Liabilities & Equity	674.28	798.14	964.8	754.15	572.01	189.19
Total Debt	8.72	9.02	10.9	10.44	8.26	3.32
Net Cash (Debt)	616.13	745.39	919.97	710.33	543.52	173.68
Net Cash Growth	-26.70%	-18.98%	29.51%	30.69%	212.94%	39.05%
Net Cash Per Share	7.85	9.57	13.75	11.73	12.46	4.82
Filing Date Shares Outstanding	77.11	76.54	75.43	63.04	52.94	36.83
Total Common Shares Outstanding	76.94	76.42	75.37	62.59	52.65	36.03
Working Capital	467.21	599.67	617.69	577.6	544.7	167
Book Value Per Share	8.24	9.88	12.31	11.53	10.45	4.76
Tangible Book Value	633.98	754.9	927.92	721.5	550.03	171.36
Tangible Book Value Per Share	8.24	9.88	12.31	11.53	10.45	4.76
Machinery	-	14.38	11.89	11	10.8	12.32
Leasehold Improvements	-	9.36	9.02	4.2	7.02	6.39

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q